Adverse events2,012

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 2,012

Type	Event	Organ system	Group	Affected	At risk	Events
other	Anaemia	Blood and lymphatic system disorders	Ramucirumab + S-1 + Oxaliplatin - Part A	25	96	37
other	Anaemia	Blood and lymphatic system disorders	Placebo + S-1 + Oxaliplatin - Part A	20	93	32
other	Anaemia	Blood and lymphatic system disorders	Ramucirumab + S-1 + Oxaliplatin Part B	15	58	19
other	Anaemia	Blood and lymphatic system disorders	Placebo + S-1 + Oxaliplatin - Part B	11	64	23
other	Disseminated intravascular coagulation	Blood and lymphatic system disorders	Ramucirumab + S-1 + Oxaliplatin - Part A	1	96	1
other	Disseminated intravascular coagulation	Blood and lymphatic system disorders	Placebo + S-1 + Oxaliplatin - Part A	1	93	1
other	Disseminated intravascular coagulation	Blood and lymphatic system disorders	Ramucirumab + S-1 + Oxaliplatin Part B	1	58	1
other	Disseminated intravascular coagulation	Blood and lymphatic system disorders	Placebo + S-1 + Oxaliplatin - Part B	0	64	0
other	Febrile neutropenia	Blood and lymphatic system disorders	Ramucirumab + S-1 + Oxaliplatin - Part A	0	96	0
other	Febrile neutropenia	Blood and lymphatic system disorders	Placebo + S-1 + Oxaliplatin - Part A	0	93	0
other	Febrile neutropenia	Blood and lymphatic system disorders	Ramucirumab + S-1 + Oxaliplatin Part B	1	58	1
other	Febrile neutropenia	Blood and lymphatic system disorders	Placebo + S-1 + Oxaliplatin - Part B	1	64	1
other	Iron deficiency anaemia	Blood and lymphatic system disorders	Ramucirumab + S-1 + Oxaliplatin - Part A	1	96	1
other	Iron deficiency anaemia	Blood and lymphatic system disorders	Placebo + S-1 + Oxaliplatin - Part A	0	93	0
other	Iron deficiency anaemia	Blood and lymphatic system disorders	Ramucirumab + S-1 + Oxaliplatin Part B	0	58	0
other	Iron deficiency anaemia	Blood and lymphatic system disorders	Placebo + S-1 + Oxaliplatin - Part B	0	64	0
other	Leukopenia	Blood and lymphatic system disorders	Ramucirumab + S-1 + Oxaliplatin - Part A	3	96	7
other	Leukopenia	Blood and lymphatic system disorders	Placebo + S-1 + Oxaliplatin - Part A	0	93	0
other	Leukopenia	Blood and lymphatic system disorders	Ramucirumab + S-1 + Oxaliplatin Part B	0	58	0
other	Leukopenia	Blood and lymphatic system disorders	Placebo + S-1 + Oxaliplatin - Part B	1	64	1

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02539225/events

API reference For AI assistants

Adverse events2,012

Sources 3

Read this list from software.